Literature DB >> 19635177

The diagnostic utility of multiple-level likelihood ratios.

Stephen C Bowden1, David W Loring.   

Abstract

Clinicians are accustomed to interpreting diagnostic test scores in terms of sensitivity and specificity. Many clinicians also appreciate that sensitivity and specificity need to be interpreted in terms of local base rates (i.e., pretest probability). However, most neuropsychological tests contain a wide range of scores. Important diagnostic information may be sacrificed when valid test scores are reduced to the simple dichotomy of "positive" or "negative" diagnosis that underlies sensitivity and specificity analysis. The purpose of this study is to provide an introduction to multiple-level likelihood ratios, a method for preserving the information in a wider range of scores. These statistics are first described using a hypothetical example of dementia screening, then with patient data from an epilepsy surgery sample. Multiple-level likelihood ratios have several advantages over sensitivity and specificity analysis because they are applied across a wider range of diagnostic scores, and generalize to settings with different base rates. We suggest that the diagnostic validity of many psychological tests may be underestimated by relying solely on traditional dichotomous sensitivity and specificity analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19635177     DOI: 10.1017/S1355617709990373

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  3 in total

1.  Testing the limits: cautions and concerns regarding the new Wechsler IQ and Memory scales.

Authors:  David W Loring; Russell M Bauer
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

2.  Diagnostic uncertainty: dichotomies are not the answer.

Authors:  Bethany Shinkins; Rafael Perera
Journal:  Br J Gen Pract       Date:  2013-03       Impact factor: 5.386

3.  Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.

Authors:  Michael B Coulthart; Gerard H Jansen; Elina Olsen; Deborah L Godal; Tim Connolly; Bernard C K Choi; Zheng Wang; Neil R Cashman
Journal:  BMC Neurol       Date:  2011-10-27       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.